This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
Tyco Provides Update On Separation Process
PEMBROKE, Bermuda: April 20, 2007 - Tyco International Ltd. (NYSE: TYC; BSX: TYC) announced today that it has filed amended Form 10 and S-1 documents with the U.S. Securities and Exchange Commission (SEC) related to its upcoming separation into three independent, publicly-traded companies.
Tyco expects the offerings described in the registration statements, along with the final separations, to be completed by the end of second calendar quarter of 2007. However, the exact timing of the separation will be dependent on the effective date of the registration statements and final approval by Tyco's Board of Directors of the tax free stock dividends for Tyco Electronics and Tyco Healthcare, now known as Covidien, to shareholders owning Tyco stock as of the record date.
ABOUT TYCO INTERNATIONAL
Tyco International Ltd. is a global, diversified company that provides vital products and services to customers in four business segments: Electronics, Fire & Security, Healthcare, and Engineered Products & Services.
OTHER INFORMATION
The Registration Statements relating to these securities have been filed with the SEC, but have not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statements become effective. Prospectus information may be obtained from Edward Arditte, Senior Vice President of Strategy & Investor Relations, Tyco International, 2nd Floor, 90 Pitts Bay Road, Pembroke HM 08, Bermuda.
Media Relations Tyco International Tyco Electronics Investor Relations Investor Relations Sheri Woodruff Ed Arditte John Roselli Cole Lannum 609-720-4399 609-720-4621 610-893-9559 508-452-4343 Karen Chin Keith Kolstrom Wayde McMillan 609-720-4398 717-986-7689 508-452-4387
Investor Relations
Tyco Healthcare